Establishment of a pair of novel cloned tumour cell lines with or without metastatic potential from canine mammary adenocarcinoma

Research in Veterinary Science

Volumn 93, Issue 1, 2012, Pages 468-472

  Murai, K ^a   Nakagawa, T ^a   Endo, Y ^a   Kamida, A ^a   Yoshida, K ^a   Mochizuki, M ^a   Nishimura, R ^a   Sasaki, N ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Caine; Characterization; Cloned cell line; Mammary adenocarcinoma; Metastasis; Xenograft

Indexed keywords

BETA CATENIN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CARCINOGENICITY; CELL CLONING; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; LUNG METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR CELL LINE; TUMOR GROWTH; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION;

MUS MUSCULUS;

EID: 84861479892     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2011.06.012     Document Type: Article

References (23)

1. Brodey R.S., Goldschmidt M.H., Roszel J.R. Canine mammary gland neoplasms. Journal of the American Animal Hospital Association 1983, 19:61-90.
2. Charpin C., Bonnier P., Garcia S., et al. E-cadherin and beta-catenin expression in breast medullary carcinomas. International Journal of Oncology 1999, 15:285-292.
3. Conacci-Sorrell M., Zhurinsky J., Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. Journal of Clinical Investigation 2002, 109:987-991.
4. Fidler I.J. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer and Metastasis Reviews 1986, 5:29-49.
5. Fu X., Le P., Hoffman R.M. A metastatic orthotopic-transplant nude-mouse model of human patient breast cancer. Anticancer Research 1993, 13:901-904.
6. Hahn K.A., Richardson R.C., Knapp D.W. Canine malignant mammary neoplasia: biologic behavior, diagnosis and treatment alternatives. Journal of the American Animal Hospital Association 1992, 28:251-256.
7. Hellmen E., Lindgren A. The expression of intermediate filaments in canine mammary glands and their tumors. Veterinary Pathology 1989, 26:420-428.
8. Henderson D., Weber K. Immuno-electron microscopical identification of the two types of intermediate filaments in established epithelial cells. Experimental Cell Research 1981, 132:297-311.
9. Hugh T.J., Dillon S.A., O'Dowd G., et al. Beta-catenin expression in primary and metastatic colorectal carcinoma. International Journal of Cancer 1999, 82:504-511.
10. Korsching E., Packeisen J., Liedtke C., et al. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?. Journal of Pathology 2005, 206:451-457.
11. Kurzman I.D., Gilbertson S.R. Prognostic factors in canine mammary tumors. Seminars in Veterinary Medicine and Surgery (Small Animal) 1986, 1:25-32.
12. MacEwen E.G., Withrow S.J. Tumors of the mammary gland. Small Animal Clinical Oncology 1996, 356-372. WB Saunders Co., Philadelphia. second ed. S.J. Withrow, E.G. MacEwen (Eds.).
13. MacEwen E.G. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer and Metastasis Reviews 1990, 9:125-136.
14. Martin P.M., Cotard M., Mialot J.P., et al. Animal models for hormone-dependent human breast cancer relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate. Cancer Chemotherapy and Pharmacology 1984, 12:13-17.
15. Moe L. Population-based incidence of mammary tumours in some dog breeds. Journal of Reproduction and Fertility 2001, 57(Suppl.):439-443.
16. Okegawa T., Li Y., Pong R.C., et al. Cell adhesion proteins as tumor suppressors. Journal of Urology 2002, 167:1836-1843.
17. Olefsky J.M. Nuclear receptor minireview series. Journal of Biological Chemistry 2001, 276:36863-36864.
18. Shofer F.S., Sonnenschein E.G., Goldschmidt M.H., et al. Histopathologic and dietary prognostic factors for canine mammary carcinoma. Breast Cancer Research and Treatment 1989, 13:49-60.
19. Simpson P.T., Reis-Filho J.S., Gale T., et al. Molecular evolution of breast cancer. Journal of Pathology 2005, 205:248-254.
20. Uyama R., Hong S.H., Nakagawa T., et al. Establishment of four pairs of canine mammary tumor cell lines derived from primary and metastatic origin and their E-cadherin expression. Veterinary and Comparative Oncology 2006, 4:104-113.
21. Wijnhoven B.P., Dinjens W.N., Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. British Journal of Surgery 2000, 87:992-1005.
22. Woodhouse E.C., Chuaqui R.F., Liotta L.A. General mechanisms of metastasis. Cancer 1997, 80:1529-1537.
23. Yoshida R., Kimura N., Harada Y., et al. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. International Journal of Oncology 2001, 18:513-520.